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Abstract:  
Salmonella Kentucky is ubiquitous in most African countries and the multidrug resistant (MDR) strains remain 
underreported across the continent. In Nigeria, poverty, inter country livestock trades, nomadic system of cattle 
production, indiscriminate use of antibiotics and prevalent immuno-compromising diseases such as human 
immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) and tuberculosis are factors that have 
enabled ease of transmission and complications of S. Kentucky infections. In the present decade, S. Kentucky is 
reported to be the most prevalent serovar associated with poultry in Nigeria, but very few reports underline the 
risk associated with consumption of poultry and acquisition of MDR S. Kentucky strains. The Nigerian poultry is one 
of the most commercialized subsectors of Nigerian agriculture, therefore, the presence of S. Kentucky especially 
strains carrying broad spectrum antimicrobial resistance pose a great risk to public health. The lack of proper 
monitoring, surveillance, isolation and control of the multidrug resistant S. Kentucky will remain a challenge to the 
export potential of the Nigerian poultry subsector and livestock in general. As a nation, modalities and actions 
against the smuggling of poultry products, indiscriminate use of antibiotics and nomadic system for the production 
of dairy and beef that promotes spread of virulent strains of Salmonellae must change. The impact of non-typhoidal 
salmonellosis in humans in Nigeria also remains under studied and under reported, especially those caused by S. 
Kentucky ST198. Compounding these concerns is the lack of commercial veterinary or human vaccines against S. 
Kentucky or where vaccines against the broad serogroup C non-typhoidal Salmonella (NTS) are available, they are 
rarely supplied, with no evidence they could be cross-protective. This review emphasizes the emergence and 
widespread occurrence of MDR S. Kentucky strains on the African continent, and discussed risk factors contributing 
to its spread in Nigeria and the potential public health challenge especially to high-risk immunocompromised 
individuals. 
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Abstrait: 
Salmonella Kentucky est omniprésente dans la plupart des pays africains et les souches multirésistantes (MDR) 
restent sous-déclarées à travers le continent. Au Nigéria, la pauvreté, les échanges de bétail entre pays, le 
système d'élevage nomade, l'utilisation aveugle d'antibiotiques et les maladies immunodéprimantes prévalentes 
telles que le virus de l'immunodéficience humaine/le syndrome d'immunodéficience acquise (VIH/SIDA) et la 




tuberculose sont des facteurs qui ont facilité la transmission et complications des infections à S. Kentucky. Au cours 
de la présente décennie, S. Kentucky serait le sérotype le plus répandu associé à la volaille au Nigéria, mais très 
peu de rapports soulignent le risque associé à la consommation de volaille et à l'acquisition de souches MDR S. 
Kentucky. La volaille nigériane est l'un des sous-secteurs les plus commercialisés de l'agriculture nigériane, par 
conséquent, la présence de S. Kentucky, en particulier les souches présentant une résistance antimicrobienne à 
large spectre, pose un grand risque pour la santé publique. L'absence de suivi, de surveillance, d'isolement et de 
contrôle adéquats du S. Kentucky multirésistant résistera toujours au défi du potentiel d'exportation du sous-
secteur de la volaille nigérian et du bétail en général. En tant que nation, les modalités et les actions contre la 
contrebande de produits de volaille, l'utilisation aveugle d'antibiotiques et le système nomade pour la production de 
produits laitiers et de boeuf qui favorisent la propagation de souches virulentes de salmonelles doivent changer. 
L'impact de la salmonellose non typhoïde chez l'homme au Nigeria reste également sous-étudié et sous-signalé, en 
particulier ceux causés par S. Kentucky ST198. À ces inquiétudes s'ajoute le manque de vaccins commerciaux 
vétérinaires ou humains contre S. Kentucky ou là où des vaccins contre les Salmonella non typhoïde du sérogroupe 
C sont disponibles, ils sont rarement fournis, sans aucune preuve qu'ils pourraient être de protection croisée. Cette 
revue met l'accent sur l'émergence et la présence généralisée de souches MDR S. Kentucky sur le continent 
africain, et a discuté des facteurs de risque contribuant à sa propagation au Nigéria et du défi potentiel de santé 
publique en particulier pour les personnes immunodéprimées à haut risque. 
Mots-clés: Salmonella Kentucky, souche ST198, multirésistante, tuberculose, VIH/SIDA, Nigéria, Afrique 
Introduction: 
 Salmonella is a Gram negative, non-
lactose fermenting and non-sporing facultative 
anaerobic rod-shaped bacteria belonging to the 
family Enterobacteriaceae (1). There are over 
2,600 different serovars and more than 50 
serogroups in the genus Salmonella as descri- 
bed in the Kauffman White scheme, and majo- 
rity of the recognized serovars cause infections 
in human and animals worldwide (2,3). Salmo- 
nella can be subdivided into two broad groups 
with respect to pathogenesis of the bacteria. 
The first group of serovars is host specific and 
typically produces systemic disease but in the 
absence of disease, these strains poorly 
colonize the intestine of their host and are 
rarely involved in human food-poisoning (4). 
Serovars in this group include Salmonella 
Gallinarum and Pullorum in poultry, Salmonella 
Dublin in cattle, and Salmonella Typhi and 
Salmonella Paratyphi A, B and C in man (5). 
 In human, Salmonella Typhi and Salm-
onella Paratyphi A are collectively referred to 
as typhoidal salmonellosis (also called enteric 
fevers) causing fatal disease of human called 
typhoid fever and paratyphoid fever respect- 
ively (5). The second group of serovars is 
known as the non-typhoidal Salmonella (NTS). 
These serovars typically produces food poiso- 
ning in man and only cause systemic disease 
under certain conditions, such as during partu- 
rition, in infants and young children, elderly, 
and immunocompromised persons (6). In 
animals, they are usually asymptomatic, but 
systemic diseases have been reported in birds 
in-lay, very young or old animals, or after 
some viral infections, and in experimental 
animals challenged with high bacterial colony 
forming units (4,7).                                       
  
 In 2010, the global incidence of human 
NTS gastroenteritis was estimated to be 93 
million cases, of which 80.3 million were via 
food-borne transmission, with over 155,000 
deaths reported (8,9). In the same year, a 
separate report on NTS gastroenteritis put the 
estimate at approximately 3.4 million invasive 
infections with 681,000 deaths; 57 % of these 
illnesses and deaths were reported to have 
occurred in Africa (10). These NTS strains can 
infect and colonize a broad range of vertebrate 
animals and most of these lineages are 
adapted to humans or may be adapted or rest- 
ricted to particular non-human animal species 
(5,11).     
 There are diversities in the epide- 
miology and host range for NTS serovars and 
their propensity to cause bloodstream infection 
and severe human disease varies (6,12). 
Invasive NTS is associated with several forms 
of immunocompromised states unlike in 
typhoidal salmonellosis, for which there are no 
clear clinical associations with classic immuno-
compromising conditions (13). These immuno-
compromising states include; disorders of 
oxidative cellular killing such as chronic granu- 
lomatous disease, in which NTS is described as 
the commonest cause of bloodstream infection 
and the third leading cause of infections (14), 
in children who are homozygous for sickle cell 
disease (15), and in people with HIV-AIDS, 
which is worsened in Africa where this disease 
is driven in part by co-infection with malaria 
(10).      
 This review attempts to provide an 
update information on the epidemiology of S. 
Kentucky in Africa and Nigeria with associated 
risk factors that may promote the acquisition 
and propagation of antimicrobial resistant 
determinants within the serovar in Nigeria and  




the impact such widespread strains may have 
on public health and the Nigerian livestock 
subsector.  
Methodology:  
 An online search of relevant published 
materials and bibliographic citations including 
review articles, original articles, books and 
conference papers through the period 1990 to 
2019 was done on Google, Google scholar, 
PubMed and African Journals Online (AJOL). 
The keywords utilized for the search were 
‘salmonellosis’, ‘Salmonella Kentucky ST198’, 
‘multidrug resistant S. Kentucky’, ‘prevalent 
Salmonella serovar in Nigeria’, ‘nontyphoidal 
salmonellosis in Nigeria’, ‘epidemiology of non- 
typhoidal salmonellosis in Africa’, ‘antimicrobial 
Salmonella pathogen’, ‘nontyphoidal salmon- 
ellosis and HIV infection in Nigeria’, ‘salmon- 
ellosis and tuberculosis infection in Nigeria’, 
‘and Salmonella Kentucky in the Nigerian cattle 
and poultry subsector’. Reference materials 
totaling 186 were identified, and following 
screening of all the materials, 79 reference 
materials were selected for the review.  
Characteristic features of S. Kentucky: 
 Salmonella enterica subsp. enterica 
serovar Kentucky (antigenic formula 8, 20: i: 
z6) is a serovar of the O: 8 (C2-C3) serogroup 
(16,17). Salmonella serogroup C consists of 
highly diverse serovars among which 37 are 
reported to account for the majority of human 
Salmonella infection as compared to 17 and 11 
serovars for serogroups B and D, respectively 
(6). Currently, four out of the ten most lethal 
serovars of Salmonella in the United States are 
from serogroup C and strains within this sero- 
group are multidrug resistant (9). Salmonella 
Kentucky on several occasions has been 
isolated from healthy poultry, dairy cows and 
occasionally from people with clinical disease 
(16,17). S. Kentucky was less often identified 
in human salmonellosis averaging 62 cases per 
annum in the United States between 1996 to 
2004, but rose to 123 cases in 2006; accord- 
ingly, the prevalence in chickens rose from 
25% in 1997 to approximately 50% in 2007 
(18-20).     
 While the virulence and colonization 
mechanism of S. Enteritidis (serogroup D), and 
S. Typhimurium (serogroup B) have been 
extensively studied, studies on S. Kentucky are 
few (21). If left unattended to, S. Kentucky 
exhibits the potential to emerge as the most 
prevalent NTS serovar in human disease as it 
has acquired virulent chromosomal and plasmid 
factors that gives it superior colonization 
capabilities of its host and environment (22-
24). Johnson et al., (22) reported that S. 
Kentucky harbors a ColV virulence plasmid 
gene which significantly increased its ability to 
colonize chicken caecum and cause extraintes- 
tinal disease through competitive exclusion. 
Turki et al., (23) identified the presence of 
virulence invA/spvC genes and quorum sensing 
sdiA gene and elucidated the ability of S. 
Kentucky to form biofilms, which is a micro- 
bially derived sessile community characterized 
by cells that are irreversibly attached to a 
substratum or interface or to each other, and 
are embedded in a matrix of extracellular 
polymeric substances (EPS) that they have 
produced, and which exhibit altered phenotype 
with respect to growth rate and gene trans- 
cription (25,26).    
 Interestingly, it has been observed that 
the resistance of biofilm cells to antimicrobials 
is significantly increased compared with what is 
normally seen with the same cells being plank- 
tonic (27,28). Thus, it is believed that biofilm 
formation enhances the capacity of pathogenic 
Salmonella bacteria to survive stresses that 
are commonly encountered both within food 
processing, as well as during host infection 
(29). These virulence factors confer on S. 
Kentucky a superior capacity to persist longer 
in the environment and explains its ability to 
acquire virulence plasmid genes from avian 
pathogenic Escherichia coli (APEC) and other 
non-generic bacteria through horizontal gene 
transfer (22,23).   
 Salmonella Kentucky ST198 is an eme- 
rging risk for foodborne illness across the globe 
(30). Whole genome sequencing of isolates 
obtained from five continents (Africa, Europe, 
Middle East, Asia and North America) showed 
that multidrug-resistant (MDR) S. Kentucky 
isolates belonged to a single lineage, which 
was estimated to emerged circa 1989 following 
the acquisition of the AMR-associated Salmo- 
nella genomic island (SGI) 1 (variant SGI1-K), 
which confers resistance to ampicillin, strepto- 
mycin, gentamicin, sulfamethoxazole and tetr-
acycline (31). The MDR clone has undergone 
substitution mutations in the quinolone-resis- 
tance-determining regions (QRDRs) of DNA gy- 
ase (gyrA) and topoisomerase IV (parC) genes, 
such that most strains carry three QRDR 
mutations which together confer resistance to 
ciprofloxacin. Remarkably, each genome of the 
MDR clone carried a different SGI1-K derivative 
structure; this variation could be attributed to 
IS26n mediated insertions and deletions (31). 
The genome sequence of S. enterica serotype 
Kentucky ST198 isolate 201001922 has been 




deposited in GenBank under the accession 
number CP028357 (31). 
Epidemiology of S. Kentucky infection in 
African countries 
 In time past, the most widely reported 
serovars associated with invasive non-typh- 
oidal salmonellosis across Africa were S.  
Typhimurium (serogroup B) and S. Enteritidis 
(serogroup D) (14,32). But recent studies are 
now showing a significant shift in the predo- 
minant Salmonella serovar associated with 
poultry and human infections (18, 24, 33). 
Salmonella Kentucky is reported to be the 
most widely spread serovar on the African 
continent where virulent strains of this bacteria 
is reported to have originated, and this is now 
of global public health concern (6,24).  
 A multiple-antibiotic resistant strain of 
S. Kentucky with multilocus sequence type 
(MLST) 198 was reported to have originated 
from Egypt. Isolates of this strain of S. 
Kentucky manifested high degree of broad 
range antibiotic resistance especially toward 
ciprofloxacin which is considered the mainstay 
drug of choice for Salmonella treatment 
(24,34). Subsequently this clone has been ide-
ntified in a number of other African countries 
(24). This strain was originally considered to 
be travel related but has now been identified in 
poultry, various food materials and environ- 
ments. This emerging strain has acquired 
chromosomal and plasmid factors over time 
that give it a superior colonization capacity in 
host animals (22). In Tunisia, 57 strains of S. 
Kentucky were isolated from different sources 
between 2005 and 2008 and were charact- 
erized by their antimicrobial and mercury resis- 
tance profiles and other virulent factors (23). A 
total of 10.6% of these isolates demonstrated 
multidrug-resistance against 3 to 13 antibiotics 
with ciprofloxacin resistance occurring in 33% 
of the human isolates (23).    
 Salmonella is considered in Morocco as 
the major cause of food poisoning in the 
country, although Salmonella cases remains 
underreported. Salmonella Kentucky resistant 
to ciprofloxacin was first identified in an eight- 
month old child who was admitted at the 
paediatric department of University Hospital 
Centre Ibn-Rochd in Casablanca, Morocco, with 
an acute febrile diarrheal illness (35,36). In a 
study of the prevalence of drug susceptibility 
and molecular characteristics of NTS isolated 
from laying hens in three Moroccan regions; 
Rabat-Salé-Zemmour-Zaër, Souss-Massa-Drâa 
and the grand Casablanca, seven Salmonella 
enterica serovars were identified; S. Enteritidis 
(37.5%), S. Kentucky (31.2%), S. Infantis (10. 
.9%), S. Typhimurium (6.2%), S. Thompson 
(6.2%), S. Agona (4.6%), and S. Amsterdam 
(3.1%). Amongst these serovars, S. Kentucky 
showed the highest level of resistance (25%) 
to the different drugs tested (37).   
 In a separate study undertaken by 
Allaoui et al., (38) in 2017 on the prevalence, 
sensitivity to antibiotics and distribution of 
Salmonella spp. serotypes in broiler turkey in 
the north-west of Morocco, twenty farms were 
inspected three times for the purpose of the 
study. S. Kentucky was the most prevalent 
serovar (33.8%) isolated, followed by S. 
Parkroyal (16.3%) and S. Agona (11.3%), and 
the results of the Salmonellae antimicrobial 
resistance showed that multi-drug resistant 
strains (resistant to three or more antibiotics) 
accounted for 80.6% of the strains isolated; 
4.8% were resistant to ceftazidime, ceftriaxone 
and cefotaxime (38) with S. Kentucky and S. 
Agona showing the highest resistance rates to 
the tested drugs. The risk factors associated 
with contamination were linked to; the clean- 
out period, antibiotic treatment, infection of 
turkey poults at placement, manure storage, 
keeping sick turkeys in the turkey house, 
season and age of turkeys at the time of 
sampling (38). The findings of a widespread 
antibiotic resistant strains and high prevalence 
of S. Kentucky reported by Allaoui et al., (38), 
was in accordance with other studies under- 
taken in other parts of Morocco (37,39-42). 
These studies established the threat posed by 
laying hens and turkey to the effective control 
of human NTS foodborne diseases in Morocco. 
 In Uganda, Afema et al., (43) reported 
a high prevalence of S. Kentucky in poultry 
and significantly high isolation rates in 
humans. Livestock (poultry, ruminant and 
swine), environmental and human samples 
were taken from 14 sites in Kampala, the 
largest city of Uganda. Thirty-two serovars of 
Salmonella were isolated from these sources 
amongst which were S. Enteritidis, S. Ken- 
tucky, S. Newport and S. Typhimurium. Intere- 
stingly, S. Enteritidis was not detected in 
human wastewater samples and S. Typhi- 
murium was poorly isolated from this sample 
(43). Sensitivity and resistance profile to 15 
antimicrobials (amikacin, amoxicillin–clavulanic 
acid, ampicillin, cefotaxime, cefoxitin, ceftiofur, 
chloramphenicol, ciprofloxacin, gentamicin, ka- 
namycin, nalidixic acid, streptomycin, sulfis- 
oxazole, tetracycline, and trimethoprim–sulfa- 
methoxazole) showed that S. Kentucky exhi- 
bited extensive multi-drug resistance pattern 
and had diverse resistance profile from human, 
environmental and poultry sources (43), for 




instance, the SSuTCipNa resistance profile was 
shared by S. Kentucky from human, environ- 
mental and poultry sources. A deca-resistant 
profile, ACKSSuSxTAmcCipNa was unique to 
poultry, and S. Kentucky isolated from poultry 
were multi-drug resistant, while other serovars 
found in poultry were pan-susceptible or had 
low resistance profile (43). Also, shared geno- 
types and antimicrobial resistance pheno- 
types were found in NTS from human, livestock 
and environmental sources, suggesting the 
occurrence of zoonotic and environmental 
transmissions (43).    
 In West Africa, reports from Ghana 
indicated that the prevalence and antimicrobial 
resistance pattern for Salmonellae was higher 
in S. Kentucky. In two regions of Ghana, fecal, 
dust, feed and drinking water samples were 
collected from 75 commercial egg-laying and 
broiler farms while skin neck samples were 
collected from broilers representing different 
flocks at a local slaughterhouse. Of the 200 
samples collected, Salmonella was detected in 
94 of them representing 47% with an overall 
flock prevalence of 44.0%. Sixteen serovars of 
Salmonella were identified with S. Kentucky 
the most prevalent (18.1%) followed by S. 
Nima (12.8%), S. Muenster (10.6%), S. Enter- 
itidis (10.6%) and S. Virchow (9.6 %). All the 
strains of S. Kentucky were reported to show 
multidrug resistance (two or more anti- 
microbials) including ciprofloxacin, nalidixic 
acid and tetracycline (44).  
 In Senegal, recent reports on the 
prevalence and presence of S. Kentucky are 
sparse but earlier findings showed fluctuations 
in their isolation rates. A total of 1623 clinical 
isolates of Salmonella belonging to 229 sero- 
types were received by the Senegalese 
Reference Center for Enterobacteria from 
January 1999 to December 2009 (45). The 
most common serotypes isolated were S. Ente- 
ritidis (19%), S. Typhi (8%), S. Typhimurium 
(7%) and S. Kentucky (4%). There were 
noticeable significant increases in the preva- 
lence of resistance to amoxicillin (0.9% in 
1999 to 11.1% in 2009) and nalidixic acid 
(0.9% in 1999 to 26.7% in 2009) in NTS 
serotypes (45). The constant threats that arise 
from sudden increase in emergence and 
prevalence of new serovars of Salmonellae are 
often due to unknown or unclear reasons (46).  
Epidemiology of S. Kentucky infection in 
Nigeria and the concern    
 Nigeria is reported to have widespread 
presence of S. Kentucky serovar, and the 
multidrug resistant strain ST198 that is now of 
global concern has been isolated (24,33,47). 
Useh et al., in 2016 (48) reported the findings 
of a study undertaken in southwest and north 
central Nigeria where epidemiological samples 
were collected, with S. Kentucky the most 
common serotype isolated from poultry in 
these regions, followed by S. Zega and S. 
Hertston, which have previously been isolated 
from diarrheal cases among children in Niger 
State. Salmonella Enteritidis, which was 
thought to be the most common serotype 
associated with poultry worldwide, was absent 
in the study.     
 Another extensive and elaborate study 
cutting across all the six geopolitical zones in 
Nigeria was undertaken (49) with represent- 
ative samples of five different types (litter, 
dust, faeces, feed and water) collected from 
commercial chicken layer farms in selected 
States in these regions. In this survey, S. 
Kentucky was the most widely spread serovar 
with prevalence of 16.2% and highest isolation 
from faeces (23%) and feeds (22.7%), follo- 
wed by S. Poona (5.6%) and S. Elisabethville. 
Also, S. Kentucky was distributed across the 
country, whereas the other less frequent 
serovars had a more circumscribed diffusion 
(49). The usual high presence in faeces also 
indicated high environmental contamination 
that allowed the pathogen to persist within the 
poultry flock.     
 In a separate study involving three 
southwestern States (Lagos, Ogun and Oyo), 
Mshelbwala et al., in 2017 (50) reported that 
S. Kentucky was the second most prevalent 
serovar with prevalence rate of 24.3%. The 
study reported further that although this 
serovar was less often associated with morta- 
lity in birds, the finding seems to contradict 
this norm (50) as sampled and challenged 
birds showed classical lesions consistent with 
that exhibited by the host specific serotypes. 
The findings of Fagbamila et al., (49) and 
Mshelbwala et al., (50) are amongst the most 
recent reports regarding S. Kentucky in the 
Nigerian poultry subsector. The risk factors 
reported in these studies that allowed for wide- 
spread presence of this serovar included poor 
biosecurity, poor sanitation measures, and lack 
of adequate monitoring and surveillance in the 
farms.     
 Earlier reports by Raufu et al., (47, 51) 
identified the presence of the highly pathogenic 
S. Kentucky ST198 strain that encode genes 
resistant to multiple antimicrobials. In the 
study, S. Kentucky isolates from chicken and 
farm environmental sources (litter, faeces, 
water) in Ibadan (southwestern) and Maiduguri 
(northeastern) Nigeria were screened to estab- 




lish for the presence of ciprofloxacin resistant 
genes (S. Kentucky CIPR strain) using pulse 
field gel electrophoresis (PFGE) and minimum 
inhibitory concentration (MIC) in 2007, 2010 
and 2011. Six percent of the samples were 
positive for S. Kentucky and all resistant to 
nalidixic acid and ciprofloxacin (47). The 
isolates showed genotypic relatedness to S. 
Kentucky CIPR strain based on XbaI PFGE 
fingerprinting, indicating the presence of wide- 
spread S. Kentucky CIPR clone within poultry 
and farm environment in these regions (47).  
 Nigeria is the most populous and one 
of the largest countries on the African 
continent, with a total geographical area of 
923,768 square kilometers (52). The estimated 
population of the country in 2013 was 174.5 
million people with a population growth rate of 
3% per annum and the National Population 
Commission (NPC) put the estimate at over 
193 million in 2016 (53,54). The Nigerian 
economic statistics reveal an economic growth 
rate that averaged over 7% per annum in 
recent decades, making Nigeria one of the 
fastest growing economies on the continent 
(55). Nonetheless, this growth has neither 
reduced poverty nor created a stable environ- 
ment for jobs thus; unemployment is still very 
high, and more than 60% of the population 
lives below the poverty line (56).  
 Poultry and cattle production play 
significant roles in the epidemiology of 
Salmonellae in Nigeria, because they act as 
reservoirs, and excrete the organism in their 
faeces, and their products are easily conta- 
minated by infected animals (49,57,58). The 
Nigerian poultry industry has expanded rapidly 
in recent years despite encountering several 
shortcomings like the global financial crisis, 
inadequate credit facilities, a weak level of 
biosecurity and a relatively low level of 
production (59). The Nigerian poultry industry 
rose from approximately 150,700 million 
chickens in 2005 to 192,313 million in 2010 
(60), thus it is one of the most commercialized 
and growing subsectors of Nigerian agriculture 
(53,61); and also accounts for about 25% of 
the country local meat production.   
 The advantages of poultry production 
over other livestock production can be 
explained by the fact that poultry birds are 
good converters of feed into useable protein in 
meat and eggs, production costs per unit 
remain relatively low, and return on invest- 
ment is high. Therefore, subsistence farmers 
need a relatively small amount of capital to 
start a poultry farm. Also, poultry meat is 
tender and acceptable to consumers, 
regardless of their religious backgrounds. 
Furthermore, the production cycle is quite 
short, so capital is not tied up for too long, and 
eggs, which is a major products of poultry 
farming, are more affordable for the common 
people than other sources of animal protein 
(62,63). This makes the poultry subsector an 
essential part of the Nigerian economy and a 
good source of high-quality protein for the 
teeming population.    
 In food-producing animals, especially 
poultry, infection with Salmonella has a direct 
impact on the global marketing of the 
respective livestock animals and livestock-
derived food products (64). The high rate of 
production of poultry in Nigeria signifies a high 
rate consumption of its products; however, this 
also means a concomitant increase in the 
cases of Salmonella-associated gastroenteritis 
(65) and thus makes S. Kentucky ST198 an 
imminent threat to the poultry subsector and a 
limiting factor to its export potential. Thus, 
prevention of Salmonella infections is impor- 
tant for the profitable expansion of the poultry 
industry. Despite this assertion, an effective 
prevention and control measure cannot be 
undertaken unless the status of the disease 
and epidemiology are well elucidated (62). 
There are very few African countries that 
report surveillance data on Salmonella and as 
such, very limited information is available on 
Salmonella isolation for the Africa continent 
(58,66).     
 One of the factors that may contribute 
to the proliferation of bacteria strains resistant 
to multiple antimicrobials in Nigeria would be 
the indiscriminate use of antimicrobials in the 
poultry subsector. Indiscriminate use of anti- 
microbials in any environment creates selec- 
tion pressures that favours the survival of 
antibiotic-resistant strains (67) and in Nigeria, 
the practice of routinely giving antimicrobials 
to domestic livestock for growth promotion and 
prophylaxis is an important factor in the 
emergence of antibiotic-resistant bacteria in 
the food chain (65,68). The occurrence of 
ciprofloxacin resistant serovar is of economic 
importance since fluoroquinolone resistance 
has implications for both veterinary and human 
therapy ciprofloxacin is a mainstay drug in the 
treatment of salmonellosis thus; the abuse of 
these medications in poultry could result in the 
emergence of resistant zoonotic bacteria (62). 
Risk factors for S. Kentucky infection 
Nomadic system of cattle rearing    
 Food animals such as cattle play 
significant roles in the epidemiology of  Salmo- 
nella, because they act as reservoirs and 




excrete Salmonellae in their faeces (57), 
therefore, meat and meat products that are 
contaminated during slaughter and processing, 
pose severe health risks, and  infections can 
also result from cattle contact (69,70). Beef 
from cattle is considered an important source 
of salmonellae in Nigeria as they are widely 
consumed, and reports have shown that they 
are source for transmission of zoonotic 
Salmonella serovar including S. Kentucky to 
man. The potential for zoonotic transmission is 
further increased given limited capacity for 
sanitation, nomadic system of cattle production 
and co-mingling of this livestock with human 
population (71).     
 In 2017, Fashae et al., (71) compared 
phenotypic and genotypic characteristics of 
Salmonellae isolated from cattle and humans 
in a study of faecal samples from diarrhoeic 
patients, healthy population, cattle beef at 
slaughter, farms, and markets. The Salmonella 
isolates were serotyped and their antimicrobial 
susceptibility pattern determined (71) while 
whole genome sequencing (WGS) of selected 
isolates and bioinformatics analysis were used 
to identify the multilocus sequence type 
(MLST), plasmid replicons, antimicrobial resis- 
tance genes, and genetic relatedness by single 
nucleotide polymorphism (SNP).   
 The MLST sequence types (ST) include 
ST 584, ST 198, ST 562 and ST 512 for S. 
Colindale, S. Kentucky S. Rubislaw and S. 
Urbana respectively. The findings in this study 
showed multiple antibiotic resistant serovar 
exhibited by S. Kentucky and S. Typhimurium. 
In the cattle market, both S. Kentucky and S. 
Ealing co-predominated (40% each) (71). 
There was an overlapping of Salmonella 
serovars between humans and cattle and also 
between the diarrhoeic patients and healthy 
women, and such serovars included S. 
Colindale, S. Give, S. Corvallis, S. Oranienburg 
and S. Kentucky. Majority (83.3%) of the resi- 
stant isolates obtained from the healthy 
women comprised six serovars including S. 
Kentucky, while all the three resistant isolates 
from cattle were S. Kentucky (71), and all the 
ciprofloxacin resistant isolates belonged to S. 
Kentucky. Furthermore, majority (57.1%) of 
the multidrug resistant (resistance to ≥3 anti- 
microbials) isolates were S. Kentucky (71). The 
findings of this study buttressed the fact that 
in Nigeria, cattle are important reservoir of 
diverse serovars of Salmonellae including the 
highly virulent multiple antimicrobial resistant 
S. Kentucky strains. 
Inter country livestock trade   
 Trading of livestock between African 
countries is an important means for the 
transmission of zoonotic pathogens between 
nations. Despite the huge potentials of the 
Nigerian poultry subsector, the 330 billion 
Naira chicken meat segment of the industry, is 
still struggling to grow because of the 
smuggling of large volumes of imported 
chicken products into her markets (72). The 
poultry industry estimates that about 1.2 
million metric tons of poultry products are 
smuggled into Nigeria annually, primarily from 
Brazil and Asia, and although the government 
of Nigeria has placed a ban on the importation 
of poultry products, implementation has not 
been effective (72).    
 The Western and Central African 
countries are reported to import large 
quantities of frozen poultry products from the 
European Union (EU). Between 1996 and 2003, 
chicken imports from the EU to ECOWAS 
countries increased from 125,000 to 860,000 
metric tons. Benin was the major importer, 
followed by Ghana, Nigeria, Senegal, Togo, 
and Côte d’Ivoire. Yet about 90 percent of 
Benin’s poultry imports are informally re-
exported to Nigeria as reported by the World 
Bank. The illegal importation of these poultry 
products, porosity and poor manning of the 
Nigeria border and inadequate surveillance 
policy on Salmonella spp. play important role 
in the acquisition and transmission of the S. 
Kentucky serovar to the country.   
Indiscriminate use of antimicrobials  
 The use antimicrobials cannot be 
overlooked by their proven importance for a 
sustainable livestock production especially in 
the control and treatment of livestock 
infections and their use as growth promoters 
(73). The use of antimicrobials in any environ- 
ment creates selection pressures that favors 
the survival of antibiotic-resistant strains (67), 
and in Nigeria, the practice of routinely 
administering antimicrobials in the livestock 
industry as growth promoters and prophylaxis 
is an important factor that promotes the 
emergence of antibiotic-resistant bacteria in 
the food chain with concomitant socioeconomic 
and public health risk (65,68,73). Furthermore, 
the abusive use of antimicrobials in many parts 
of the world is recognized as key drivers for 
the emergence and spread of antimicrobial 
resistance (74-77).    
 In a study conducted by multi-stage 
sampling technique of 454 farmers in 11 com- 
munities within 11 Local Government Areas 
(LGAs) of Kaduna and Oyo States in northern 
and southern Nigeria respectively to ascertain 
antimicrobials usage and practices by livestock 




farmers in these regions of the country (73). 
Antimicrobial usages were collected through 
interviews, questionnaire and focus group 
discussions. The study revealed that anti- 
microbials were widely distributed, easily 
accessible and commonly used in livestock 
production, and antimicrobials that are crucial 
in human therapy including flouroquinolones 
were widely used in animals as prophylactics. 
Also, potentially harmful antimicrobials incl- 
uding furazolidones and chloramphenicol which 
have been banned for use in humans and 
animals were freely marketed and used in 
livestock production (73). Most of the respon- 
dents in the study acknowledged that it was 
standard practice for drugs and antimicrobials 
to be prescribed and administered to animals, 
but on the farm, they buy and administer 
antimicrobials without professional consultation 
(73).      
 In another study, Ogunleye et al., (78) 
in 2010 reported the widespread occurrence of 
multidrug resistant Salmonella serovars from 
poultry disease outbreaks in two southwestern 
Nigerian states (Oyo and Ogun) where a total 
of 73.3% of Salmonella isolates tested were 
multi-drug resistant (resistance to four or eight 
antibiotics) which included resistance to cipro- 
floxacin, nalidixic acid, chloramphenicol, strep- 
tomycin, kanamycin, ampicillin, neomycin, and 
tetracycline, and specifically, 63.4% were cipr- 
ofloxacin resistant (78). The practice of avoid- 
ing veterinary personnel and laboratory invest- 
igations in the diagnosis of disease prior to 
institution of antimicrobial therapy could lead 
to improper usage that promotes the develop- 
ment of antimicrobial resistance in bacterial 
strains (73).  
Use of antimicrobial residue in animal feed 
 The indiscriminate use of therapeutic 
and prophylactic antimicrobials administered in 
feedstuffs in the Nigerian livestock industry is a 
managerial practice that gives opportunity for 
antimicrobials to enter the human food chain 
(through eggs, milk, meat, etc.) especially 
when drug withdrawal periods are not adhered 
to (79). Medicated feedstuffs are primarily a 
mixture of animal feed and veterinary 
medicinal products, which are usually author- 
ized for the animal species for which the feed 
is intended and contains high antimicrobial 
concentrations depending on its aim, physio- 
logical status and state of health of the animal. 
 The use of these feedstuffs accom- 
panied by the tendencies for human error in 
compounding and contamination of the anti- 
biotic negative feed with antimicrobials, imp- 
roper production, poor handling and storage 
practices, little proportions of medicated feed- 
stuff being left in production line or storage 
tanks leading to the cross-contamination of 
next batches of antimicrobial negative feed, 
pose severe risks and safety concerns to both 
animals and man (79), and promote the 
spread of antibiotic resistant pathogens such 
as S. Kentucky ST198. 
Potential challenges of S. Kentucky NTS to 
HIV/AIDS patients 
 Data from the United Nations Progra- 
mme on human immunodeficiency virus  and 
the acquired immune deficiency syndrome 
(UNAIDS) put the estimate number of people 
in Nigeria living with HIV in 2018 at 1.9 million 
(80) which makes the nation the second larg- 
est HIV epidemic in the world and approxim- 
ately 160,000 people died from AIDS related 
illnesses in Nigeria in 2017 (81). Although new 
survey indicates that Nigeria has HIV preva- 
lence among adults (aged 15 – 49 years) at 
1.5%, this was previously estimated at 2.8% 
(82), and the recent drops in prevalence 
estimates for Nigeria were attributed to better 
surveillance (83). Six States in Nigeria that 
account for 41% of people living with HIV are 
Kaduna, Akwa Ibom, Benue, Lagos, Oyo, and 
Kano (84) but the prevalence of HIV is highest 
in Nigeria southern states (known as the 
south-south zone) at 5.5% and lowest in the 
southeast zone with a prevalence of 1.8%. 
Previous reports showed that there are higher 
rates of HIV in rural areas (4%) than in urban 
ones (3%) (85).     
 Reports have indicated that the use of 
antimicrobials for growth-promotion, prophy- 
laxis, and treatment of food animals increases 
the prevalence of resistance in human 
pathogens, particularly NTS in people living 
with HIV/AIDS. Researches to ascertain the 
prevalence of NTS amongst people living with 
HIV/AIDS has been undertaken in the country. 
In Ekiti State, a study was undertaken to 
evaluate the relationship between consumption 
of poultry products and prevalence of HIV 
/AIDS, with collection of 100 stool and 50 
blood samples from a total of 150 HIV/AIDS 
patients attending Federal Medical Centre, Ido-
Ekiti, and 50 faecal samples from broiler 
chickens for culture and identification of NTS 
as well as their antimicrobial susceptibilities 
and similarities (86). Eighteen NTS isolates 
were identified from the human with a preva- 
lence of 12% while four NTS isolates were 
identified from poultry broiler-chicken with 
prevalence of 8%. Isolates from broiler 
chickens had a higher average resistance to 




seven commonly prescribed antibiotics includ- 
ing ciprofloxacin (78.6%) when compared to 
the human isolate (53.9%). Furthermore, most 
of the isolates from human and broiler chicken 
showed resistance to more than one antibiotic 
expressing the concern that antimicrobial 
resistance is wide spread in both poultry and 
persons living with HIV/AIDS (86). 
Potential challenges of S. Kentucky NTS to 
tuberculosis patients 
 The lack of epidemiological data on the 
impact of NTS on tuberculosis (TB) or records 
implicating opportunistic infections caused by 
antimicrobial resistant Salmonellae on TB 
patients is rare. In 1995, a 33 years old 
woman with recurrent Salmonella Enteritis 
infection was found to have underlying hepatic 
tuberculosis (87). Ciprofloxacin, ceftriaxone, 
penicillin and chloramphenicol were among the 
antimicrobials administered that failed to 
eradicate the recurrent nontyphoidal salmo- 
nellosis. Over the past decades, S. Kentucky 
has been identified as most prevalent multi- 
drug resistant Salmonella serovar in human 
salmonellosis infection (22, 24).  
 The World Health organization priori- 
tizes fluoroquinolone resistant Salmonellae 
amongst the high-risk pathogens to human 
health (31) and because mycobacterium, 
causative agent for TB, are fairly susceptible to 
quinolones, repeated ciprofloxacin therapy 
which is the main stay drug for treatment of 
Salmonellosis can mask early and proper 
diagnosis of TB (87). Since antimicrobial resis- 
tance, HIV and poverty are the backbone for 
the spread of tuberculosis globally (88), and 
with these conditions endemic in Africa and 
Nigeria, it becomes pertinent for the Nigerian 
government and health organizations to draft 
up policies as they design national TB control 
programme that will prevent possible compli- 
cations caused by this pathogen.     
 It should be noted that Nigeria is 
ranked among the 30 high TB burden countries 
of the world and one of the top three of ten 
countries that accounted for 80% of the total 
gap between TB incidence and reported cases 
in 2017 (89,90). Studies from settings outside 
Nigeria reveal poor governance practices as 
responsible for the increased scourge in the 
country. The lack of specific TB legislation, 
inconsistencies in the enforcement of policies 
on isolation of TB patients in health facilities 
(91,92), Low government funding (93,94), 
inadequate trained personnel and lack of public 
awareness (95), poor integration into the 
general health system, weak programme impl- 
ementation, sub-optimal quality of care in the 
private sector, and insufficient advocacy 
around TB (88) limited the strategic vision and 
responsiveness of TB control programmes. 
Multidrug resistant (MDR) TB cases have made 
this menace terrifying for patients. Taking 
cognizance of the high incidence and epidemio- 
logic significance of occurrence of MDR-TB 
strains, it is imperative that determination of 
MDR-TB burden and complications that may be 
due to S. Kentucky ST198 in acquisition of 
MDR-TB strains in patients be elucidated to 
inform proper case management and overall 
planning of TB control activities. 
Conclusion: 
 The World health organization priori- 
tizes fluoroquinolone resistant Salmonellae 
amongst the high-risk pathogens to human 
health and S. Kentucky ST198 wears this cap.  
The genomic/genetic efficiency of this strain 
has put it in the frontline as an emerging 
threat to public health and the commercial 
livestock subsector. The lack of epidemiological 
data, proper monitoring and surveillance sys- 
tems, and indiscriminate use of antimicrobials 
in Nigeria and the African continent has 
enabled the widespread propagation of this 
serovar. On a continent where poverty and 
immuno-compromising diseases such as HIV/ 
AIDS and tuberculosis are endemic, S. Ken- 
tucky ST198 has shown explicit potential as an 
ideal opportunistic non-typhoidal Salmonella 
serovar that could compound these conditions.  
 The private sectors, government agen- 
cies and international organizations on the 
African continent are key players that can be 
involved in forestalling the propagation of this 
strain in the environment. Strategic policies 
can be made and informed decisions taken to 
curtail the spread of S. Kentucky ST198, for 
example, there should be regulations and 
restrictions on the use and over-the-counter 
sale of veterinary antimicrobials, provision of 
biosecurity facilities and trained personnel at 
inter country livestock markets and meat 
slaughtering/processing plants, adequate surv- 
eillance, monitoring and data recording prac- 
tices are measures that can limit its spread. 
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